Your browser doesn't support javascript.
loading
Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease.
Estilo, Alvin; Tracy, LaRee; Matthews, Carol; Riggen, Michele; Stemhagen, Annette; Wilt, Timothy; Krakovich, Anatoliy; Jones-Burton, Charlotte; George, Vinu; McQuade, Robert; Rahman, Mirza.
Afiliação
  • Estilo A; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
  • Tracy L; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
  • Matthews C; UBC, Blue Bell, PA, USA.
  • Riggen M; UBC, Blue Bell, PA, USA.
  • Stemhagen A; UBC, Blue Bell, PA, USA.
  • Wilt T; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
  • Krakovich A; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
  • Jones-Burton C; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
  • George V; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
  • McQuade R; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
  • Rahman M; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA.
Clin Kidney J ; 15(8): 1553-1561, 2022 Aug.
Article em En | MEDLINE | ID: mdl-36824061
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article